February 6, 2008

The FDA has stated it decision to take enforcement action against any company marketing injectable Colchicine that is unapproved. Anextremely toxic drug, Colchicine is used to treat gout and can very easily be given in excessive doses, resulting in serious side effects, low blood counts, organ failure, cardiac events and even death. 

The FDA has received 50 reports of events involving injectable Colchicine, 23 of which resulted in death.
 

The FDA states, “Individuals and companies must stop making these products within 30 days and stop shipping the product within 180 days or face regulatory action. After these dates, all injectable colchicine drug products must have FDA approval to be manufactured or shipped interstate.” For information please visit this web site: http://resource4thepeople.com/recalleddrugs/colchicine.html